GENERAL DESCRIPTION:
Vinpocetine improves brain
energy and blood supply and has been
used as a preventative and a
treatment for stroke and other brain injury.
It acts as a cerebral metabolic activator, which may improve cerebral circulation and
enhance oxygen and glucose utilization in the brain.
Vinpocetine may diminish or reduce disturbances due to
hypoxia or to deficient cerebral metabolism.
ROLE FOR ANTI-AGING:
Vinpocetine’s anti-aging benefits may include
prevention and treatment of stroke and other brain injuries, improved aged conditions caused by
poor brain blood circulation, particularly eyesight and
hearing, improved concentration, treatment and alleviation
of the problems of menopause and increased potential lifespan. Studies have found that Vinpocetine activates neurons in an area of the brain
known as the locus coeruleus. The gradual reduction in the
activity of locus coeruleus neurons that occurs with aging
is known to play a significant role in the reduction
of concentration, alertness, and learning. Thus, the stimulation of these neurons by vimpocetine
may help to relieve some of the symptoms of cognitive
decline.
SIDE EFFECTS/CONTRAINDICATIONS:
Side effects are rare but may include nausea,
skin eruption and individual hypersensitivity. Patients thought to be in complete homeostasis after
cerebral hemorrhage should avoid vinpocetine. Although only
applicable to high doses, if hypersensitive signs occur,
discontinue use.
PHARMACOLOGY: Synonyms:
Apovincaminate; Ethyl Apovincaminoate;
RGH4405.
Chemical Name:
(3alpha,l6alpha) eburnamenine-14-carboxylate.
Molecular Formula:
Molecular Weight:
Distribution:
available in 1mg, 5mg and 10mg tablets under the trade names
Cavinton, Remedial, and Vincaton.
